Evaluation of co-processed excipients for Ezetimibe liq

Journal of Pharmaceutics & Drug Delivery Research .ISSN: 2325-9604

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Evaluation of co-processed excipients for Ezetimibe liquisolid formulation

Mai Subhi Khanfar

Jordan University of Science and Technology, Jordan
: J Pharm Drug Deliv Res


Introduction: Liquisolid technique is a powdered solution technology used to convert a liquid medicament into an acceptably flowing & compressible powder by physical blending with selected excipients. Materials & Methods: In this study, the Ezetimibe will be used with new co-processed excipients (compacted chitin magnesium silicate and/or mannitol & their physical mixtures) & compared to Avicel® PH101 & Aerosil®200 that were used in the original mathematical method of Spireas et al (1998) with the aim of having a novel multifunctional excipient that act as carrier, coating, disintegrant at the same time, thus reducing cost & drug excipient interactions. Results & Discussion: Compacted powder blends containing different ratios of chitin, magnesium silicate &/or mannitol were prepared using roller compacter and tested for their surface area, particle size & flow ability to be compared with avicel and then liquisolid compacts were prepared according to Spireas. For all prepared liquisolid formulation, interactions between the drug & selected excipients had been detected by a lot of techniques. Co-processing of excipients using roll compactor has a remarkable improvement in the flow ability, and compressibility of the powder. Conclusion: The best dissolution profile was achieved by using the compacted chitin: mannitol (20:80).



Track Your Manuscript